Who Needs People, Anyway?

Scientists at Lawrence Livermore National Laboratory work too hard. So officials have decided to cope with a 3% cut in the lab's 1990 budget by telling everybody to stay home as much as possible. This is how it works: Director John Nuckolls has asked the lab's 8,000 employees to use up all of the vacation time they earn this year, as well as one fourth of the time they have accrued during their tenure at the lab. The money to pay vacation time comes out of a different pot from the money for reg

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Scientists at Lawrence Livermore National Laboratory work too hard. So officials have decided to cope with a 3% cut in the lab's 1990 budget by telling everybody to stay home as much as possible. This is how it works: Director John Nuckolls has asked the lab's 8,000 employees to use up all of the vacation time they earn this year, as well as one fourth of the time they have accrued during their tenure at the lab. The money to pay vacation time comes out of a different pot from the money for regular salaries; as a result, Nuckolls figures the lab can "save" almost $30 million in operating funds by paying people from the account reserved for vacation time. The catch, of course, is getting people to leave their work benches. Lab spokesperson Jean Madden says that, so far, people aren't complaining. In fact, she says, "I took six ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies